The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle
Abstract
In oncological research, there is a great need for imaging techniques that specifically identify angiogenic blood vessels in tumors on the basis of differences in the expression level of biomolecular markers. In the angiogenic cascade, different cell surface receptors, including the αvβ3‐integrin, are strongly expressed on activated endothelial cells. In the present study, we aimed to image angiogenesis by detecting the expression of αvβ3 in tumor bearing mice with a combination of magnetic resonance imaging (MRI) and fluorescence microscopy. To that end, we prepared MR‐detectable and fluorescent liposomes, which carry ∼700 αvβ3‐specific RGD peptides per liposome. RGD competition experiments and RAD‐conjugated liposomes were used as controls for specificity. In vivo, both RAD liposomes and RGD liposomes gave rise to signal increase on T 1 ‐weighted MR images. It was established by the use of ex vivo fluorescence microscopy that RGD liposomes and RAD liposomes accumulated in the tumor by different mechanisms. RGD liposomes were specifically associated with activated tumor endothelium, while RAD liposomes were located in the extravascular compartment. This study demonstrates that MR molecular imaging of angiogenesis is feasible by using a targeted contrast agent specific for the αvβ3‐integrin, and that the multimodality imaging approach gave insight into the exact mechanism of accumulation in the tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Rouser, G., Fleischer, S., & Yamamoto, A. (1970) · Lipids · doi:10.1007/bf02531316 · Cited by 3,274
Arg-Gly-Asp: A versatile cell recognition signal
Ruoslahti, E., & Pierschbacher, M. D. (1986) · Cell · doi:10.1016/0092-8674(86)90259-x · Cited by 1,397
Weissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Imaging of angiogenesis: from microscope to clinic
McDonald, D. M., & Choyke, P. L. (2003) · Nature Medicine · doi:10.1038/nm0603-713 · Cited by 1,016
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Self-citationαv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Scaling down imaging: molecular mapping of cancer in mice
Weissleder, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc701 · Cited by 708
Haubner, R., Gratias, R., Diefenbach, B., Goodman, S. L., Jonczyk, A., & Kessler, H. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9603721 · Cited by 582
Haubner, R., Wester, H. J., Weber, W., Mang, C., Ziegler, S. I., Goodman, S. L., Senekowitsch–Schmidtke, R., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 563
MRI of the tumor microenvironment
Gillies, R. J., Raghunand, N., Karczmar, G. S., & Bhujwalla, Z. M. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10181 · Cited by 550
Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions
Padhani, A. R. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10176 · Cited by 472
Long-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 445
Haubner, R., Finsinger, D., & Kessler, H. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199713741 · Cited by 430
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 371
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 331
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
Schiffelers, R. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00240-2 · Cited by 310
Liposomen: Möglichkeiten der Medikamentenfreisetzung
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI
Morawski, A. M., Winter, P. M., Crowder, K. C., Caruthers, S. D., Fuhrhop, R. W., Scott, M. J., Robertson, J. D., Abendschein, D. R., Lanza, G. M., & Wickline, S. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20010 · Cited by 271
Thumshirn, G., Hersel, U., Goodman, S. L., & Kessler, H. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200204304 · Cited by 269
Zitzmann, S., Ehemann, V., & Schwab, M. (2002) · PubMed · Cited by 265
Chen, X., Park, R., Tohme, M., Shahinian, A. H., Bading, J. R., & Conti, P. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0300403 · Cited by 260
A Liposomal System for Contrast-Enhanced Magnetic Resonance Imaging of Molecular Targets
Mulder, W. J. M., Strijkers, G. J., Griffioen, A. W., van Bloois, L., Molema, G., Storm, G., Koning, G. A., & Nicolay, K. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049949r · Cited by 233
Self-citationFluorescently Detectable Magnetic Resonance Imaging Agents
Hüber, M. M., Staubli, A. B., Kustedjo, K., Gray, M. H. B., Shih, J., Fraser, S. E., Jacobs, R. E., & Meade, T. J. (1998) · Bioconjugate Chemistry · doi:10.1021/bc970153k · Cited by 204
Dafni, H., Israely, T., Bhujwalla, Z. M., Benjamin, L. E., & Neeman, M. (2002) · PubMed · Cited by 169
Micro-PET Imaging of αvβ3-Integrin Expression with 18F-Labeled Dimeric RGD Peptide
Chen, X., Tohme, M., Park, R., Hou, Y., Bading, J. R., & Conti, P. S. (2004) · Molecular Imaging · doi:10.1162/1535350041464892 · Cited by 159
Kok, R. J., Schraa, A. J., Bos, E. J., Moorlag, H. E., Ásgeirsdóttir, S. A., Everts, M., Meijer, D. K. F., & Molema, G. (2001) · Bioconjugate Chemistry · doi:10.1021/bc015561+ · Cited by 146
Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting
Dubey, P. K., Mishra, V., Jain, S., Mahor, S., & Vyas, S. P. (2004) · Journal of drug targeting · doi:10.1080/10611860410001728040 · Cited by 144
Hölig, P., Bach, M., Völkel, T., Nahde, T., Hoffmann, S., Müller, R., & Kontermann, R. E. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh055 · Cited by 129
Multimodality in Vivo Molecular-Genetic Imaging
Doubrovin, M., Serganova, I. S., Mayer‐Kuckuk, P., Ponomarev, V., & Blasberg, R. G. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0498572 · Cited by 111
Dijkhuizen, R. M., Asahi, M., Wu, O., Rosen, B. R., & Lo, E. H. (2002) · Stroke · doi:10.1161/01.str.0000023534.37670.f7 · Cited by 104
Molecular Imaging Applications in Nanomedicine
Li, K. C., Pandit, S. D., Guccione, S., & Bednarski, M. D. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000031747.05317.81 · Cited by 90
MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles☆
Dardzinski, B. J., Schmithorst, V. J., Holland, S. K., Boivin, G. P., Imagawa, T., Watanabe, S., Lewis, J. M., & Hirsch, R. (2001) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(01)00448-9 · Cited by 88
Peptide-targeted PEG-liposomes in anti-angiogenic therapy
Janssen, A. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00682-8 · Cited by 79
Schraa, A. J., Kok, R. J., Moorlag, H. E., Bos, E. J., Proost, J. H., Meijer, D. K. F., de Leij, L. F. M. H., & Molema, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10727 · Cited by 73
Alterations in Endothelial F-Actin Microfilaments in Rabbit Aorta in Hypercholesterolemia
Colangelo, S. M., Langille, B. L., Steiner, G. A., et al. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.1.52 · Cited by 49
Combined vascular targeted imaging and therapy: A paradigm for personalized treatment
Li, K. C., Guccione, S., & Bednarski, M. D. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10401 · Cited by 26
Cited by
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Multimodality Imaging Probes: Design and Challenges
Louie, A. (2010) · Chemical Reviews · doi:10.1021/cr9003538 · Cited by 1,044
Nanoplatforms for Targeted Molecular Imaging in Living Subjects
Cai, W., & Chen, X. (2007) · Small · doi:10.1002/smll.200700351 · Cited by 563
Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging
Mulder, W. J. M., Strijkers, G. J., van Tilborg, G. A. F., Griffioen, A. W., & Nicolay, K. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1011 · Cited by 535
Self-citationApplications of nanoparticles for diagnosis and therapy of cancer
Baetke, S. C., Lammers, T., & Kiessling, F. (2015) · The British Journal of Radiology · doi:10.1259/bjr.20150207 · Cited by 494
Metadata
- Authors
- Mulder, W. J. M., Strijkers, G. J., Habets, J. W., Bleeker, E. J. W., van der Schaft, D. W. J., Storm, G., Koning, G. A., Griffioen, A. W., & Nicolay, K.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-10-04
- Volume
- 19
- Issue
- 14
- Pages
- 2008-2010
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2115060917
- Cited by
- 259
- References
- 42
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.